Brooks Completes $79M Purchase of Nexus Biosystems

The deal is a step in Brooks' goal of making itself the "market and innovation leader in biobanking and compound sample management."

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories